Fundz
Real-time · AI · Cross-signal

Bluejay Diagnostics just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Bluejay Diagnostics, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024•almost 2 years ago

Contract Type

partnership

ActonHealthcareHealth Caremedical devices

Description

Bluejay Diagnostics, Inc. announced the closing of a firm commitment underwritten public offering with gross proceeds expected to be approximately $8.75 million. The company intends to use the net proceeds from the offering to repay $2.3 million and for general corporate purposes.

Company Information

Company

Bluejay Diagnostics

Location

360 MASSACHUSETTS AVENUE, SUITE 203

Acton, Massachusetts, United States

About

Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient product for triage and monitoring of disease progression.

Predictive Intelligence
Strategic

ML-powered predictions for Bluejay Diagnostics's next move

Learn about Strategic plan

Related People

Suggested for you

Choose your plan to reveal verified contacts

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months